Intraoral Versus Extraoral Manual Therapy in Subjects With Temporomandibular Disorders

Sponsor
University of Alcala (Other)
Overall Status
Recruiting
CT.gov ID
NCT05167656
Collaborator
(none)
90
1
3
18.7
4.8

Study Details

Study Description

Brief Summary

The aim of this randomized controlled trial is to evaluate the effects of intraoral manual therapy versus extraoral manual therapy and compare them with a control group, in the management of patients with temporomandibular disorders regarding pain, strength, quality of life, disability and anxiety.

Condition or Disease Intervention/Treatment Phase
  • Other: Intraoral manual therapy
  • Other: Extraoral manual therapy
  • Other: Exercise and counselling
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
Researchers involved in recording outcome measures will not be aware of treatment allocation. Patients will be encouraged to not tell the evaluators about the received treatment.
Primary Purpose:
Treatment
Official Title:
Intraoral Versus Extraoral Manual Therapy in Subjects With Temporomandibular Disorders. A Randomized Controlled Trial
Actual Study Start Date :
Apr 12, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Nov 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intraoral Manual Therapy plus exercise and education.

Six sessions of intraoral manual therapy plus exercise and counselling.

Other: Intraoral manual therapy
Six intraoral manual therapy sessions based on ischemic compression and pain pressure release of the temporomandibular region muscles, applied bilateral.

Other: Exercise and counselling
Information about etiology, contributing and related factors, natural history and prognostic of the pathology of temporomandibular disorders. Counselling based on: diet, habits like tabacism, stress and anxiety control, physical activity and awareness of dental clenching. Exercise daily program based on active and passive mobility of the temporomandibular joint, stretching exercises and self massage.

Experimental: Extraoral Manual Therapy plus exercise and education.

Six sessions of extraoral manual therapy plus exercise and counselling.

Other: Extraoral manual therapy
Six extraoral manual therapy sessions based on ischemic compression, pain pressure release and pressure sliding of the temporomandibular region muscles, applied bilateral.

Other: Exercise and counselling
Information about etiology, contributing and related factors, natural history and prognostic of the pathology of temporomandibular disorders. Counselling based on: diet, habits like tabacism, stress and anxiety control, physical activity and awareness of dental clenching. Exercise daily program based on active and passive mobility of the temporomandibular joint, stretching exercises and self massage.

Active Comparator: Exercise and education.

Exercise and counselling alone without any manual therapy treatment.

Other: Exercise and counselling
Information about etiology, contributing and related factors, natural history and prognostic of the pathology of temporomandibular disorders. Counselling based on: diet, habits like tabacism, stress and anxiety control, physical activity and awareness of dental clenching. Exercise daily program based on active and passive mobility of the temporomandibular joint, stretching exercises and self massage.

Outcome Measures

Primary Outcome Measures

  1. Change in pain intensity [Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment.]

    Pain intensity measured with numerical pain rating scale which ranges from 0 points (no pain) to 10 points (worst imaginable pain)

Secondary Outcome Measures

  1. Change in pain pressure threshold [Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment.]

    Pain pressure threshold measured by a digital algometer at several locations of temporomandibular joint.

  2. Change in range of movement of the temporomandibular joint [Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment.]

    Active and passive range of movement measured by a digital caliper.

  3. Change in quality of life [Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment.]

    Quality of life measured with Short Form Health Survey (SF-12). SF-12 ranges from 0 (poor quality of life) to 100 (great quality of life).

  4. Change in disability [Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment.]

    Disability measured with Craniofacial Pain and Disability Inventory (CF-PDI). CF-PDI ranges from 0 (better functional status) to 63 (worse disability).

  5. Change in anxiety [Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment.]

    Anxiety measured with State-Trait Anxiety Inventory (STAI). STAI ranges from 20 (lower anxiety) to 80 (greater anxiety).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Unilateral temporomandibular pain for more than one month.

  • Older than eighteen.

  • No previous treatment to temporomandibular pain in the last 3 months.

  • Diagnosed based on the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD).

Exclusion Criteria:
  • Patients with cervical or cranial trauma or whiplash.

  • Diagnosed with systemic disease, like rheumatoid arthritis or fibromyalgia.

  • Diagnosed of any vascular or metabolic disease.

  • Previous cervical or temporomandibular surgery.

  • Dental, medicine or any physical therapy treatment in the last 3 months before the beginning of the interventions.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alcalá Alcalá De Henares Madrid Spain 28805

Sponsors and Collaborators

  • University of Alcala

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jorge Ballesteros Frutos, Principal Investigator, University of Alcala
ClinicalTrials.gov Identifier:
NCT05167656
Other Study ID Numbers:
  • CEID/2021/4/087
First Posted:
Dec 22, 2021
Last Update Posted:
May 23, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 23, 2022